Denali Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- August 26, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $130,000,000
Company Info
- Founders
- Marc Tessier-Lavigne, Ryan Watts, Alex Schuth
- Company Description
- Denali Therapeutics is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, ALS and others.
- Market
- Neurodegenerative diseases
- Location
- San Francisco, California, USA
- Coinvestors
- Alaska Permanent Fund, ARCH Venture Partners, Baillie Gifford, Fidelity Biosciences, Flagship Ventures